Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 4/2014

01-04-2014 | Ischemic Heart Disease (D Mukherjee, Section Editor)

Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis: an Updated Review of Literature

Authors: Saurav Chatterjee, Dharam Jaydeep Kumbhani, Partha Sardar, Anasua Chakraborty, Giuseppe Biondi-Zoccai, Manpreet Singh Sabharwal, Richard Ro, Balaji Pratap, Chirag P. Bavishi, Sripal Bangalore

Published in: Current Cardiology Reports | Issue 4/2014

Login to get access

Abstract

Recent trials have highlighted the comparable mortality benefits and durability of the results for patients with severe aortic stenosis (AS) and high surgical risk managed with either transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (AVR). Various national guidelines and international regulatory bodies have approved TAVR, thereby leading to potential wide usage and dissemination of this technique worldwide. Quality-of-life outcomes, in spite of being an important measure of success and acceptability of the procedure, have not been publicized as extensively. For high risk patients with severe AS, implementation of TAVR has resulted in comparable survival, but different and novel adverse events compared with AVR. We present an updated review focusing on the quality-of-life outcomes and issues with this new and important procedural approach.
Literature
1.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.PubMedCrossRef
2.•
Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;5:1220–5. This study provides an overview of the wide-spread prevalence of aortic stenosis in the elderly, and indicates the need for effective and safe treatment for the same. CrossRef
3.
Ross Jr J, Braunwald E. Aortic stenosis. Circulation. 1968;38(1 Suppl):61–7.PubMed
4.
Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105–10.PubMedCrossRef
5.
Sundt TM, Bailey MS, Moon MR, et al. Quality of life after aortic valve replacement at the age of 80 years. Circulation. 2000;102:III70–4.PubMedCrossRef
6.
Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Jr FDP, Freed MD, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1–142.PubMedCrossRef
7.
Bouma BJ, van Den Brink RB, van Der Meulen JH, Verheul HA, Cheriex EC, Hamer HP, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart. 1999;82:143–8.PubMedCentralPubMed
8.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–43.PubMedCrossRef
9.
Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290–5 [Epub Jun 13, 2005].PubMedCrossRef
10.
Bach DS, Siao D, Girard SE, Duvernoy C, McCallister Jr BD, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2:533–9.PubMedCrossRef
11.
Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214–23.PubMedCrossRef
12.
Bavry AA, Kumbhani DJ. Indications and techniques of percutaneous procedures: Coronary, Peripheral, and Structural Heart Disease. UK: Springer; 2012.CrossRef
13.
Kodali SK, O'Neill WW, Moses JW, Williams M, Smith CR, Tuzcu M, et al. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol. 2011;107:1058–64.PubMedCrossRef
14.
Svensson LG, Dewey T, Kapadia S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008;86:46–54.PubMedCrossRef
15.
Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. Heart Lung Transplant. 2001;20:1016–24.CrossRef
16.
Dolgin M. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston: Brown and Co; 1994.
17.
Supino PG, Borer JS, Franciosa JA, Preibisz JJ, Hochreiter C, Isom OW, et al. Acceptability and psychometric properties of the Minnesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36. J Card Fail. 2009;15:267–77.PubMedCrossRef
18.
Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245–55.PubMedCrossRef
19.
Failde I, Ramos I. Validity and reliability of the SF-36 Health Survey Questionnaire in patients with coronary artery disease. J Clin Epidemiol. 2000;53:359–65.PubMedCrossRef
20.
Lukkarinen H, Hentinen M. Assessment of quality of life with the Nottingham Health Profile among patients with coronary heart disease. J Adv Nurs. 1997;26:73–84.PubMedCrossRef
21.
The Euro QoL Group. Euro-Qol: a new facility for measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef
22.
Chiappini B, Camurri N, Loforte A, Di Marco L, Di Bartolomeo R, Marinelli G. Outcome after aortic valve replacement in octogenarians. Ann Thorac Surg. 2004;78:85–9.PubMedCrossRef
23.
Kolh P, Kerzmann A, Honore C, Comte L, Limet R. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg. 2007;31:600–6.PubMedCrossRef
24.
Spaziano M, Carrier M, Pellerin M, Choiniere M. Quality of life following heart valve replacement in the elderly. J Heart Valve Dis. 2010;19:524–32.PubMed
25.
Shan L, Saxena A, McMahon R, Wilson A, Newcomb A. A systematic review on the quality of life benefits after aortic valve replacement in the elderly. J Thorac Cardiovasc Surg. 2013;145:1173–89.
26.
Ussia GP, Mule M, Barbanti M, et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J. 2009;30:1790–6.PubMedCrossRef
27.
Bekeredjian R, Krumsdorf U, Chorianopoulos E, Kallenbach K, Karck M. Katus, et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol. 2010;106:1777–81.PubMedCrossRef
28.••
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607. This study was the first randomized trial that showed mortality benefits with transcatheter aortic valve implantation in comparison with ‘standard therapy’ in patients unable to undergo surgical valve replacement. PubMedCrossRef
29.•
Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, et al. Placement of Aortic Transcatheter Valves (PARTNER) Investigators. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011;124:1964–72. This study was a prespecified, prospective cohort nested within the randomized PARTNER trial (cohort B) that showed significant improvements in QoL with TAVR when compared with similar patients on ‘standard therapy’. PubMedCrossRef
30.•
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98. This study established comparable efficacy and safety of TAVR contrasted with surgical AVR. PubMedCrossRef
31.•
Reynolds MR, Magnuson EA, Wang K, Thourani VH, Williams M, Zajarias A, et al. PARTNER Trial Investigators. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (cohort A). J Am Coll Cardiol. 2012;60:548–58. This study was a prespecified, prospective cohort nested within the randomized PARTNER trial(cohort A) that showed significant improvements in QoL with TAVR when compared with similar patients undergoing surgical AVR. PubMedCrossRef
32.
Grossi EA, Zakow PK, Ribakove G, et al. Comparison of postoperative pain, stress response, and quality of life in port access vs standard sternotomy coronary bypass patients. Eur J Cardiothorac Surg. 1999;16 Suppl 2:S39–42.PubMedCrossRef
33.
Walther T, Falk V, Metz S, et al. Pain and quality of life after minimally invasive versus conventional cardiac surgery. Ann Thorac Surg. 1999;67:1643–7.PubMedCrossRef
34.
Georgiadou P, Kontodima P, Sbarouni E, et al. Long-term quality of life improvement after transcatheter aortic valve implantation. Am Heart J. 2011;162:232–7.PubMedCrossRef
35.
Gotzmann M, Bojara W, Lindstaedt M, et al. One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis. Am J Cardiol. 2011;107:1687–92.PubMedCrossRef
36.
Krane M, Deutsch MA, Piazza N, Muhtarova T, Elhmidi Y, Mazzitelli D, et al. One-year results of health-related quality of life among patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2012;109:1774–81.PubMedCrossRef
37.
Alli OO, Booker JD, Lennon RJ, Greason KL, Rihal CS, Holmes Jr DR. Transcatheter aortic valve implantation: assessing the learning curve. J Am Coll Cardiol Intv. 2012;5:72–9.CrossRef
38.
Kala P, Tretina M, Poloczek M, Ondrasek J, Malik P, Pokorny P, et al. Quality of life after transcatheter aortic valve implantation and surgical replacement in high-risk elderly patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157:75–80.PubMedCrossRef
39.
Stortecky S, Schmid V, Windecker S, Kadner A, Pilgrim T, Buellesfeld L, et al. Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation. Euro Interv. 2012;8:437–43.
40.
Amonn K, Stortecky S, Brinks H, Gahl B, Windecker S, Wenaweser P, et al. Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement. Eur J Cardiothorac Surg. 2013;43:34–41.PubMedCrossRef
Metadata
Title
Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis: an Updated Review of Literature
Authors
Saurav Chatterjee
Dharam Jaydeep Kumbhani
Partha Sardar
Anasua Chakraborty
Giuseppe Biondi-Zoccai
Manpreet Singh Sabharwal
Richard Ro
Balaji Pratap
Chirag P. Bavishi
Sripal Bangalore
Publication date
01-04-2014
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 4/2014
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-014-0473-8

Other articles of this Issue 4/2014

Current Cardiology Reports 4/2014 Go to the issue

Interventional Cardiology (S Rao, Section Editor)

Same Day Discharge After Elective Percutaneous Coronary Intervention

Interventional Cardiology (S Rao, Section Editor)

Choosing the Right Coronary Stent in the Modern Era

Nuclear Cardiology (V Dilsizian, Section Editor)

Novel Molecular Angiotensin Converting Enzyme and Angiotensin Receptor Imaging Techniques

Nuclear Cardiology (V Dilsizian, Section Editor)

Assessing the Prognostic Implications of Myocardial Perfusion Studies: Identification of Patients at Risk vs Patients who May Benefit from Intervention?

Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Endogenous Sex Hormones, Metabolic Syndrome, and Diabetes in Men and Women

Valvular Heart Disease (VT Nkomo, Section Editor)

Infective Endocarditis: Therapeutic Options and Indications for Surgery

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits